Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer

Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (CRT), are often offered short-course radiotherapy followed by delayed surgery (SCRT-delay). This entails a lower radiation dose, no chemotherapy and a shorter treatment period. This may lower their chances for comp...

Full description

Saved in:
Bibliographic Details
Published in:European journal of surgical oncology 2018-07, Vol.44 (7), p.1013-1017
Main Authors: Hoendervangers, Sieske, Couwenberg, Alice M., Intven, Martijn P.W., van Grevenstein, Wilhelmina M.U., Verkooijen, Helena M.
Format: Article
Language:English
Subjects:
Chemoradiation
Locally advanced rectal cancer
Pathological complete response
Short course radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923
cites cdi_FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923
container_end_page 1017
container_issue 7
container_start_page 1013
container_title European journal of surgical oncology
container_volume 44
creator Hoendervangers, Sieske
Couwenberg, Alice M.
Intven, Martijn P.W.
van Grevenstein, Wilhelmina M.U.
Verkooijen, Helena M.
description Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (CRT), are often offered short-course radiotherapy followed by delayed surgery (SCRT-delay). This entails a lower radiation dose, no chemotherapy and a shorter treatment period. This may lower their chances for complete tumor response and, as such, organ-sparing approaches. The purpose of this study was to compare the pathological complete response (pCR) rates between neoadjuvant CRT and SCRT-delay in patients with LARC in a nationwide database from the Netherlands. In the population based Netherlands Cancer Registry, clinical stage III rectal cancer patients, diagnosed between 2008 and 2014, who underwent CRT or SCTR-delay were selected. pCR (ypT0N0), near pCR (ypT0-1N0), and tumor and nodal downstaging were compared between the treatment groups using multivariable logistic regression analysis. 386 patients underwent SCRT-delay and 3659 patients underwent CRT. The pCR-rate in the SCRT-delay group was significantly lower compared to the CRT-group (6.4% vs. 16.2%, p 
doi_str_mv 10.1016/j.ejso.2018.03.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2025313661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798318309624</els_id><sourcerecordid>2025313661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923</originalsourceid><addsrcrecordid>eNp9kctu1TAQhi0EoqctL8ACeckmwZdcHIkNOmqhUiU2dG059qTHkRMH2ynKS_GMdTiFJSuPPd_845kfofeUlJTQ5tNYwhh9yQgVJeElodUrdKA1ZwWjdfsaHUhbiaLtBL9AlzGOhJCOt91bdMG6piYV7Q7o99FPiwo2-hn7AS8qnbzzj1Yrh3VOOUiAA8TFzzEHKkHEakgQ8AxemXF9UnPC8eRDKrRfwx_IWJ9OENSyYR-wPsHk90eVbO4yeOf8LzC437ABp7YcxjU8QtiwnbHzubXbsDJZWedcAJ32z-y3cI3eDMpFePdyXqGH25sfx2_F_fevd8cv94XmdZOKWlEqBKe0bYVqQRPBSW8aw4moNG_6CmhHeV-TehBUN0wbPrBBd6JvKCMd41fo41l3Cf7nCjHJyUYNzqk89holI6zmlDcNzSg7ozr4GAMMcgl2UmGTlMjdJznK3Se5-yQJl9mnXPThRX_tJzD_Sv4ak4HPZwDylE8Wgozawr4Quy9EGm__p_8MfHqo2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2025313661</pqid></control><display><type>article</type><title>Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer</title><source>ScienceDirect Freedom Collection</source><creator>Hoendervangers, Sieske ; Couwenberg, Alice M. ; Intven, Martijn P.W. ; van Grevenstein, Wilhelmina M.U. ; Verkooijen, Helena M.</creator><creatorcontrib>Hoendervangers, Sieske ; Couwenberg, Alice M. ; Intven, Martijn P.W. ; van Grevenstein, Wilhelmina M.U. ; Verkooijen, Helena M.</creatorcontrib><description>Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (CRT), are often offered short-course radiotherapy followed by delayed surgery (SCRT-delay). This entails a lower radiation dose, no chemotherapy and a shorter treatment period. This may lower their chances for complete tumor response and, as such, organ-sparing approaches. The purpose of this study was to compare the pathological complete response (pCR) rates between neoadjuvant CRT and SCRT-delay in patients with LARC in a nationwide database from the Netherlands. In the population based Netherlands Cancer Registry, clinical stage III rectal cancer patients, diagnosed between 2008 and 2014, who underwent CRT or SCTR-delay were selected. pCR (ypT0N0), near pCR (ypT0-1N0), and tumor and nodal downstaging were compared between the treatment groups using multivariable logistic regression analysis. 386 patients underwent SCRT-delay and 3659 patients underwent CRT. The pCR-rate in the SCRT-delay group was significantly lower compared to the CRT-group (6.4% vs. 16.2%, p &lt; 0.001). After adjustment for clinical tumor stage, clinical nodal stage and time interval to surgery, SCRT-delay patients were significantly less likely to reach pCR (adjusted odds ratio 0.3, 95%CI 0.2–0.5). Also, near-pCR (ypT0–1N0) as well as tumor and nodal downstaging was observed less often in the SCRT-delay group. Compared to patients treated with neoadjuvant CRT, those receiving SCRT and delayed surgery are less likely to develop pCR. Novel neoadjuvant treatment strategies for patients not fit enough for CRT are needed to increase their eligibility for organ-sparing treatments.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2018.03.014</identifier><identifier>PMID: 29650419</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chemoradiation ; Locally advanced rectal cancer ; Pathological complete response ; Short course radiotherapy</subject><ispartof>European journal of surgical oncology, 2018-07, Vol.44 (7), p.1013-1017</ispartof><rights>2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology</rights><rights>Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923</citedby><cites>FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923</cites><orcidid>0000-0001-7017-9817</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29650419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoendervangers, Sieske</creatorcontrib><creatorcontrib>Couwenberg, Alice M.</creatorcontrib><creatorcontrib>Intven, Martijn P.W.</creatorcontrib><creatorcontrib>van Grevenstein, Wilhelmina M.U.</creatorcontrib><creatorcontrib>Verkooijen, Helena M.</creatorcontrib><title>Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (CRT), are often offered short-course radiotherapy followed by delayed surgery (SCRT-delay). This entails a lower radiation dose, no chemotherapy and a shorter treatment period. This may lower their chances for complete tumor response and, as such, organ-sparing approaches. The purpose of this study was to compare the pathological complete response (pCR) rates between neoadjuvant CRT and SCRT-delay in patients with LARC in a nationwide database from the Netherlands. In the population based Netherlands Cancer Registry, clinical stage III rectal cancer patients, diagnosed between 2008 and 2014, who underwent CRT or SCTR-delay were selected. pCR (ypT0N0), near pCR (ypT0-1N0), and tumor and nodal downstaging were compared between the treatment groups using multivariable logistic regression analysis. 386 patients underwent SCRT-delay and 3659 patients underwent CRT. The pCR-rate in the SCRT-delay group was significantly lower compared to the CRT-group (6.4% vs. 16.2%, p &lt; 0.001). After adjustment for clinical tumor stage, clinical nodal stage and time interval to surgery, SCRT-delay patients were significantly less likely to reach pCR (adjusted odds ratio 0.3, 95%CI 0.2–0.5). Also, near-pCR (ypT0–1N0) as well as tumor and nodal downstaging was observed less often in the SCRT-delay group. Compared to patients treated with neoadjuvant CRT, those receiving SCRT and delayed surgery are less likely to develop pCR. Novel neoadjuvant treatment strategies for patients not fit enough for CRT are needed to increase their eligibility for organ-sparing treatments.</description><subject>Chemoradiation</subject><subject>Locally advanced rectal cancer</subject><subject>Pathological complete response</subject><subject>Short course radiotherapy</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1TAQhi0EoqctL8ACeckmwZdcHIkNOmqhUiU2dG059qTHkRMH2ynKS_GMdTiFJSuPPd_845kfofeUlJTQ5tNYwhh9yQgVJeElodUrdKA1ZwWjdfsaHUhbiaLtBL9AlzGOhJCOt91bdMG6piYV7Q7o99FPiwo2-hn7AS8qnbzzj1Yrh3VOOUiAA8TFzzEHKkHEakgQ8AxemXF9UnPC8eRDKrRfwx_IWJ9OENSyYR-wPsHk90eVbO4yeOf8LzC437ABp7YcxjU8QtiwnbHzubXbsDJZWedcAJ32z-y3cI3eDMpFePdyXqGH25sfx2_F_fevd8cv94XmdZOKWlEqBKe0bYVqQRPBSW8aw4moNG_6CmhHeV-TehBUN0wbPrBBd6JvKCMd41fo41l3Cf7nCjHJyUYNzqk89holI6zmlDcNzSg7ozr4GAMMcgl2UmGTlMjdJznK3Se5-yQJl9mnXPThRX_tJzD_Sv4ak4HPZwDylE8Wgozawr4Quy9EGm__p_8MfHqo2g</recordid><startdate>20180701</startdate><enddate>20180701</enddate><creator>Hoendervangers, Sieske</creator><creator>Couwenberg, Alice M.</creator><creator>Intven, Martijn P.W.</creator><creator>van Grevenstein, Wilhelmina M.U.</creator><creator>Verkooijen, Helena M.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7017-9817</orcidid></search><sort><creationdate>20180701</creationdate><title>Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer</title><author>Hoendervangers, Sieske ; Couwenberg, Alice M. ; Intven, Martijn P.W. ; van Grevenstein, Wilhelmina M.U. ; Verkooijen, Helena M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Chemoradiation</topic><topic>Locally advanced rectal cancer</topic><topic>Pathological complete response</topic><topic>Short course radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoendervangers, Sieske</creatorcontrib><creatorcontrib>Couwenberg, Alice M.</creatorcontrib><creatorcontrib>Intven, Martijn P.W.</creatorcontrib><creatorcontrib>van Grevenstein, Wilhelmina M.U.</creatorcontrib><creatorcontrib>Verkooijen, Helena M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoendervangers, Sieske</au><au>Couwenberg, Alice M.</au><au>Intven, Martijn P.W.</au><au>van Grevenstein, Wilhelmina M.U.</au><au>Verkooijen, Helena M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2018-07-01</date><risdate>2018</risdate><volume>44</volume><issue>7</issue><spage>1013</spage><epage>1017</epage><pages>1013-1017</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (CRT), are often offered short-course radiotherapy followed by delayed surgery (SCRT-delay). This entails a lower radiation dose, no chemotherapy and a shorter treatment period. This may lower their chances for complete tumor response and, as such, organ-sparing approaches. The purpose of this study was to compare the pathological complete response (pCR) rates between neoadjuvant CRT and SCRT-delay in patients with LARC in a nationwide database from the Netherlands. In the population based Netherlands Cancer Registry, clinical stage III rectal cancer patients, diagnosed between 2008 and 2014, who underwent CRT or SCTR-delay were selected. pCR (ypT0N0), near pCR (ypT0-1N0), and tumor and nodal downstaging were compared between the treatment groups using multivariable logistic regression analysis. 386 patients underwent SCRT-delay and 3659 patients underwent CRT. The pCR-rate in the SCRT-delay group was significantly lower compared to the CRT-group (6.4% vs. 16.2%, p &lt; 0.001). After adjustment for clinical tumor stage, clinical nodal stage and time interval to surgery, SCRT-delay patients were significantly less likely to reach pCR (adjusted odds ratio 0.3, 95%CI 0.2–0.5). Also, near-pCR (ypT0–1N0) as well as tumor and nodal downstaging was observed less often in the SCRT-delay group. Compared to patients treated with neoadjuvant CRT, those receiving SCRT and delayed surgery are less likely to develop pCR. Novel neoadjuvant treatment strategies for patients not fit enough for CRT are needed to increase their eligibility for organ-sparing treatments.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29650419</pmid><doi>10.1016/j.ejso.2018.03.014</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7017-9817</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2018-07, Vol.44 (7), p.1013-1017
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_2025313661
source ScienceDirect Freedom Collection
subjects Chemoradiation
Locally advanced rectal cancer
Pathological complete response
Short course radiotherapy
title Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A58%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20pathological%20complete%20response%20rates%20after%20neoadjuvant%20short-course%20radiotherapy%20or%20chemoradiation%20followed%20by%20delayed%20surgery%20in%20locally%20advanced%20rectal%20cancer&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Hoendervangers,%20Sieske&rft.date=2018-07-01&rft.volume=44&rft.issue=7&rft.spage=1013&rft.epage=1017&rft.pages=1013-1017&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2018.03.014&rft_dat=%3Cproquest_cross%3E2025313661%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-5a1188311778a7ec0830bd6d3084c36b4e1913b505f81c62cd3f2fc98b6120923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2025313661&rft_id=info:pmid/29650419&rfr_iscdi=true